Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/mus.28307 | DOI Listing |
EClinicalMedicine
June 2024
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.
Background: Interstitial lung disease (ILD) is a common manifestation of idiopathic inflammatory myopathies (IIM) and a substantial contributor to hospitalisation, increased morbidity, and mortality. In-vivo evidence of ongoing tissue remodelling in IIM-ILD is scarce. We aimed to evaluate fibroblast activation in lungs of IIM-patients and control individuals using ⁶⁸Ga-labelled inhibitor of Fibroblast-Activation-Protein (FAPi) based positronic emission tomography and computed tomography imaging (PET/CT).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!